Skip to main content
. 2017 Nov 24;9:45–49. doi: 10.1016/j.conctc.2017.11.010

Table 4.

Additional analyses of NSCLC patients using patient-to-Accrual framework.

Characteristic Not available (n = 13) Available (n = 140) P value Available but not eligible (n = 64) Available and eligible (n = 76) P value
Smoking status
Never
Former
Current
0 (0.0)
10 (76.9)
3 (23.1)
40 (28.6)
75 (53.6)
25 (17.9)
0.08 17 (26.6)
26 (40.6)
21 (32.8)
23 (30.3)
49 (64.5)
4 (5.3)
<0.0001
Stage and line of treatment
Stage 1 or 2
Stage 3
Stage 4: First line therapy
Stage 4: Second line therapy or greater
0 (0.0)
12 (92.3)
1 (7.7)
0 (0.0)
15 (10.7)
15 (10.7)
54 (38.6)
56 (40.0)
<0.0001 12 (18.8)
12 (18.8)
22 (34.4)
18 (28.1)
3 (4.0)
3 (4.0)
32 (42.1)
38 (50.0)
<0.0001
Type of initial appointment
Diagnosis or treatment
Consult only
10 (76.9)
3 (23.1)
57 (40.7)
83 (59.3)
0.012 31 (48.4)
33 (51.6)
26 (34.2)
50 (65.8)
0.09